Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016991 (7-Fluoro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016990 (2-(4-Methoxy-benzyl)-3,7-dimethyl-5-propyl-benzofu...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50017001 (7-Chloro-2-(2,4-dimethoxy-benzyl)-3-methyl-5-propy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50017000 (5-Allyl-7-chloro-2-(4-methoxy-benzyl)-3-methyl-ben...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016987 (7-Chloro-2-(4-methoxy-benzyl)-3,5-dipropyl-benzofu...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016998 (7-Chloro-2-(4-chloro-benzyl)-3-methyl-5-propyl-ben...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016994 (2-Benzyl-7-chloro-3-methyl-5-propyl-benzofuran-4-o...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016985 (2-(4-Methoxy-benzyl)-3-methyl-5-propyl-benzofuran-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016989 (7-Chloro-2-(4-methoxy-benzyl)-3,5-dimethyl-benzofu...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 46 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50404997 (CHEMBL18295) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405004 (CHEMBL282504) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 63 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016992 (7-Chloro-5-(3-hydroxy-propyl)-2-(4-methoxy-benzyl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM32020 (4-[4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]pyro...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Patents Similars | PDB PubMed | n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405001 (CHEMBL273783) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016997 (5-tert-Butyl-7-chloro-2-(4-methoxy-benzyl)-3-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 99 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50017002 (CHEMBL18559 | [4-(7-Chloro-4-hydroxy-3-methyl-5-pr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 105 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016991 (7-Fluoro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 129 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016985 (2-(4-Methoxy-benzyl)-3-methyl-5-propyl-benzofuran-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405003 (CHEMBL428525) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016990 (2-(4-Methoxy-benzyl)-3,7-dimethyl-5-propyl-benzofu...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405007 (CHEMBL18721) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016992 (7-Chloro-5-(3-hydroxy-propyl)-2-(4-methoxy-benzyl)...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 161 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50404998 (CHEMBL276330) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016993 (7-Chloro-5-ethoxymethyl-2-(4-methoxy-benzyl)-3-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016999 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-benzofuran-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 376 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405002 (CHEMBL19036) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Inhibition of 5-lipoxygenase reaction catalyzed by purified enzyme from porcine leukocytes | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405010 (CHEMBL18672) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 440 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016988 (2-(4-Methoxy-benzyl)-3-methyl-benzofuran-4-ol | CH...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 574 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50404999 (CHEMBL282502) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016996 (5,7-Dichloro-2-(4-methoxy-benzyl)-3-methyl-benzofu...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 860 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50152559 (4-Biphenyl-4-yl-2,4-dioxo-butyric acid | CHEMBL182...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405000 (CHEMBL18773) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405005 (CHEMBL279530) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016999 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-benzofuran-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Rattus norvegicus) | BDBM50016988 (2-(4-Methoxy-benzyl)-3-methyl-benzofuran-4-ol | CH...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of arachidonic acid oxidation by rat 5-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405009 (CHEMBL19028) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50016995 (3-[7-Chloro-4-hydroxy-2-(4-methoxy-benzyl)-3-methy...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 2.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50125793 (4-(4-Cyclohexyl-phenyl)-2-hydroxy-4-oxo-but-2-enoi...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid 5-lipoxygenase (Homo sapiens (Human)) | BDBM50009004 ((phenidone)1-Phenyl-pyrazolidin-3-one | 1-Phenyl-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 9.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Concentration required for 50 % inhibition of leukotriene B4 production in human PMN compared with controls in the absence of compound | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
2-Hydroxyacid oxidase 1 (Homo sapiens (Human)) | BDBM50405006 (CHEMBL275811) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem | PubMed | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description In vitro inhibition of porcine Glycolate oxidase | J Med Chem 26: 1196-200 (1983) BindingDB Entry DOI: 10.7270/Q27082K8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Seed linoleate 13S-lipoxygenase-1 (Glycine max (soybean)) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Inhibitory activity of the compound towards soybean lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid lipoxygenase ALOX15 (Homo sapiens (Human)) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Inhibition of partially purified 15-lipoxygenase from human leukocytes | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Polyunsaturated fatty acid lipoxygenase ALOX15 (Sus scrofa) | BDBM50016986 (7-Chloro-2-(4-methoxy-benzyl)-3-methyl-5-propyl-be...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Frosst Canada Inc. Curated by ChEMBL | Assay Description Inhibitory activity of the compound towards porcine 12-lipoxygenase | J Med Chem 32: 1190-7 (1989) BindingDB Entry DOI: 10.7270/Q2ST7NVR | |||||||||||
More data for this Ligand-Target Pair |